ZEOX · Zeo ScientifiX, Inc. · Shareholders & Ownership
Substantial doubt about the company's ability to continue as a going concern.
“As of April 30, 2026, based on the factors described above, the Company concluded that there was substantial doubt about its ability to continue to operate as a going concern for the 12 months following the issuance of these financial statements. In addition, the Company's independent registered public accounting firm, in its report on the Company's October 31, 2025 financial statements, has expressed substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Jun 15, 2026
One customer — 14.2% of revenue (the six months ended April 30, 2026)
“During the six months ended April 30, 2026, the Company sold products and services totaling approximately $571,000 (14.2%) to a large medical practice group and distributor”
One customer — 12.7% of revenue (the six months ended April 30, 2026)
“and approximately $511,000 (12.7%) to another large medical practice group and distributor.”
One customer — 15.2% of revenue (the six months ended April 30, 2025)
“$341,000 (15.2%)”
One customer — 12.1% of revenue (the six months ended April 30, 2025)
“During the six months ended April 30, 2025, the Company sold products and services totaling approximately $270,000 (12.1%) to a large distributor”
One customer — 10.2% of revenue (the six months ended April 30, 2025)
“and $228,000 (10.2%) to two individual medical practices.”
Every disclosed holder of ZEOX in one list: 13F institutions, Schedule 13D and 13G filers, insiders (Forms 3, 4 and 5) and registered funds, each from its own latest filing. Holders nest by CIK and SEC reporting links, never by name, and each is summed once.
Who Owns ZEOX
| Holder group | Shares | % Out |
|---|---|---|
| Institutional (13F) | 0 | 0.00% |
| Insiders (Forms 3, 4, 5) | 2,384,486 | 30.42% |
| 13D/G-only blocks | 333,333 | 4.25% |
| Remaining | 5,119,622 | 65.32% |
| Registered funds (N-PORT, not summed) | 0 | 0.00% |
Shares outstanding: 7,837,441, the issuer's latest cover-page count restated onto today's split basis.
13D/G-only counts each filer's latest 13D or 13G that no 13F report of the listing contains, that names no 13F filer and that no counted insider files. Funds are never summed: their shares sit inside their advisers' 13F reports.
Holders of ZEOX
| # | Holder | Shares | As of | Notes |
|---|---|---|---|---|
| 1 |
|
2,117,500 | ||
| 2 |
|
1,820,094 | ||
| 2.1 |
|
915,094 | ||
| 3 |
Shapiro George Craig
13G
CIK 1804141 · Unknown · Jun 10, 2026
Rule 13d-1(d), exempt investor, not summed
|
1,311,271 | ||
| 3.1 |
Shapiro George Craig
Insider
CIK 1804141 · Jan 14, 2026
Director, Chief Medical Officer, issuer-wide
|
578,021 | ||
| 4 |
|
461,371 | ||
| 4.1 |
|
416,371 | ||
| 5 |
|
425,000 | ||
| 6 |
|
333,333 | ||
| 7 |
|
50,000 |
Shares are restated onto today's split basis. Change compares each row with the same holder's previous filing in the same source; a dash means there is none to compare. Nested 13D/G, insider and fund rows are not summed, since a 13F report already holds them.